The purpose of the present invention is to provide substance having exceptional antibacterial activity against Pseudomonas aeruginosa, and a drug composition for treatment and/or prevention of pseudomonal infections. Provided is a drug composition containing an antibody which specifically binds to the LPS 011 antigen of Pseudomonas aeruginosa, and which has exceptional antibacterial activity.